Skip to content Skip to navigation

Physician Issues

Rx Summit: Local solutions to crisis require collective effort

April 17, 2017  |  Gary A. Enos, Editor
article
Small counties in California are reducing improper opioid prescribing and expanding addiction treatment through the efforts of groups that include an insurer and a major foundation.

Role-playing technology assists health providers in substance use screening

April 16, 2017  |  Gary A. Enos, Editor
article
Use of health simulation technology is helping physicians, nurses and other general health providers take on what can be uncomfortable conversations with patients about substance use.

Ohio enacts limits on prescribing for acute pain

April 4, 2017  |  Gary A. Enos, Editor
news
New regulations on opioid prescribing in Ohio arrive at a time when some lawmakers are advocating even stricter limits.

Brightside Clinic hires medical director

March 20, 2017  |  Gary A. Enos, Editor
news
David Kushner, DO, FACP, has been named medical director at Brightside Clinic, the buprenorphine treatment organization with offices in two Illinois communities.

Report: Risk of long-term opioid use increases in initial week of treatment

March 17, 2017  |  Gary A. Enos, Editor
article
Data released this week by the Centers for Disease Control and Prevention (CDC) make a case for significant limits on initial prescriptions of opioids.

Public health researchers recommend safe injection facilities in Baltimore

March 15, 2017  |  Gary A. Enos, Editor
news
Johns Hopkins researchers suggest that two safe injection facilities (SIFs) in Baltimore would have a significant impact on reducing harms from the opioid crisis.

Study highlights threat of dual use of buprenorphine and other opioids

March 7, 2017  |  Rachael Zimlich, RN, Contributing Writer
article
Research using a pharmacy database leads to striking findings about the prevalence of other opioid use during and after buprenorphine treatment.

Researchers quantify benefit of medication intervention in emergency care

February 14, 2017  |  Gary A. Enos, Editor
news
New research suggests that opioid-addicted individuals who receive buprenorphine during an emergency medical visit show better treatment engagement for two months following the intervention.

New Jersey opioid law mandates prescriber discussions with young patients

February 8, 2017  |  Gary A. Enos, Editor
news
Advocates believe a newly adopted New Jersey law designed to educate youths and their families about the dangers of opioid addiction could add momentum for other opioid-focused legislation.

ASAM partners on training of NPs, PAs in buprenorphine prescribing

January 17, 2017  |  Gary A. Enos, Editor
news
The American Society of Addiction Medicine (ASAM) has partnered with associations representing nurse practitioners and physician assistants to offer training courses for these professionals in buprenorphine prescribing.

Five facts about new versions of buprenorphine

January 13, 2017  |  Gary A. Enos, Editor
article
Injectable and implant versions of buprenorphine are seen as potentially significant breakthroughs in improving medication adherence and reducing diversion.

Specialty provider sees increasingly receptive audience in general medicine for addiction training

January 5, 2017  |  Gary A. Enos, Editor
article
The medical director at Caron Treatment Centers reports that today's young physicians are much more likely than their predecessors to address patients' substance use concerns head-on.

Pages

Subscribe to Physician Issues